ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

Comprehensive advances in HER2-positive and HER2-negative breast cancer: unveiling molecular mechanisms and exploring cutting-edge targeted therapies for enhanced patient outcomes.

Nayan Sood et al.PubMed ↗Publisher ↗

No numbers read from the abstract.